🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

John P. Mueller

NKT Therapeutics (United States)

ORCID: 0000-0001-9368-4015

Also affiliated with Innoviva (United States)

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicineEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: Susceptibility Trends of Zoliflodacin against Multidrug-Resistant Neisseria gonorrhoeae Clinical Isolates in Nanjing, China, 2014 to 2018.

27 citations

Xiaohong Su, Xiangdi Lou, Xuechun Li, Xiangdong Gong, Baoxi Wang +4 more

0 citations

Xiaohong Su, Xiangdi Lou, Xuechun Li, Xiangdong Gong, Baoxi Wang +4 more

54 citations

Nicole A. P. Lieberman, Clara Pérez‐Mañá, Clara Suñer, Martí Vall Mayans, María Ubals +10 more